BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27440387)

  • 1. LMWH in the prevention of preeclampsia and fetal growth restriction in women without thrombophilia. A systematic review and meta-analysis.
    Mastrolia SA; Novack L; Thachil J; Rabinovich A; Pikovsky O; Klaitman V; Loverro G; Erez O
    Thromb Haemost; 2016 Oct; 116(5):868-878. PubMed ID: 27440387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-molecular-weight heparin for the prevention of preeclampsia in high-risk pregnancies without thrombophilia: a systematic review and meta-analysis.
    Chen J; Huai J; Yang H
    BMC Pregnancy Childbirth; 2024 Jan; 24(1):68. PubMed ID: 38233773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a prior history - an open-label randomised trial (the EPPI trial): study protocol.
    Groom KM; McCowan LM; Stone PR; Chamley LC; McLintock C;
    BMC Pregnancy Childbirth; 2016 Nov; 16(1):367. PubMed ID: 27876004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-molecular-weight heparin for prevention of preeclampsia and other placenta-mediated complications: a systematic review and meta-analysis.
    Cruz-Lemini M; Vázquez JC; Ullmo J; Llurba E
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1126-S1144.e17. PubMed ID: 34301348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.
    Roberge S; Nicolaides K; Demers S; Hyett J; Chaillet N; Bujold E
    Am J Obstet Gynecol; 2017 Feb; 216(2):110-120.e6. PubMed ID: 27640943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Prophylactic Enoxaparin for the Prevention of Preeclampsia and Intrauterine Growth Restriction: A Randomized Trial.
    Llurba E; Bella M; Burgos J; Mazarico E; Gómez-Roig MD; De Diego R; Martínez-Astorquiza T; Alijotas-Reig J; Sánchez-Durán MÁ; Sánchez O; Carreras E; Cabero L
    Fetal Diagn Ther; 2020; 47(11):824-833. PubMed ID: 33472201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low molecular weight heparin versus no treatment in women with previous severe pregnancy complications and placental findings without thrombophilia.
    Kupferminc M; Rimon E; Many A; Maslovitz S; Lessing JB; Gamzu R
    Blood Coagul Fibrinolysis; 2011 Mar; 22(2):123-6. PubMed ID: 21192252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial.
    Groom KM; McCowan LM; Mackay LK; Lee AC; Said JM; Kane SC; Walker SP; van Mens TE; Hannan NJ; Tong S; Chamley LW; Stone PR; McLintock C;
    Am J Obstet Gynecol; 2017 Mar; 216(3):296.e1-296.e14. PubMed ID: 28153659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women.
    Mello G; Parretti E; Fatini C; Riviello C; Gensini F; Marchionni M; Scarselli GF; Gensini GF; Abbate R
    Hypertension; 2005 Jan; 45(1):86-91. PubMed ID: 15557391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dalteparin and low-dose aspirin in the prevention of adverse obstetric outcomes in women with inherited thrombophilia.
    Leduc L; Dubois E; Takser L; Rey E; David M
    J Obstet Gynaecol Can; 2007 Oct; 29(10):787-93. PubMed ID: 17915061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study.
    Riyazi N; Leeda M; de Vries JI; Huijgens PC; van Geijn HP; Dekker GA
    Eur J Obstet Gynecol Reprod Biol; 1998 Sep; 80(1):49-54. PubMed ID: 9758259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis.
    Bujold E; Morency AM; Roberge S; Lacasse Y; Forest JC; Giguère Y
    J Obstet Gynaecol Can; 2009 Sep; 31(9):818-826. PubMed ID: 19941706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis.
    Roberge S; Demers S; Nicolaides KH; Bureau M; Côté S; Bujold E
    Ultrasound Obstet Gynecol; 2016 May; 47(5):548-53. PubMed ID: 26481090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined Anticoagulant Therapy for Prevention of Preeclampsia and Small for Gestational Age Neonates: A Systematic Review and Meta-analysis.
    Kontovazainitis CG; Gialamprinou D; Katsaras GN; Pouliakis A; Theodoridis T; Mitsiakos G
    Am J Perinatol; 2023 Dec; 40(16):1745-1764. PubMed ID: 35235957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil During Pregnancy: A Preclinical Meta-Analysis on Fetal Growth and Maternal Blood Pressure.
    Paauw ND; Terstappen F; Ganzevoort W; Joles JA; Gremmels H; Lely AT
    Hypertension; 2017 Nov; 70(5):998-1006. PubMed ID: 28893896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological Interventions for the Prevention of Fetal Growth Restriction: A Systematic Review and Network Meta-Analysis.
    Bettiol A; Avagliano L; Lombardi N; Crescioli G; Emmi G; Urban ML; Virgili G; Ravaldi C; Vannacci A
    Clin Pharmacol Ther; 2021 Jul; 110(1):189-199. PubMed ID: 33423282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombophilia, preeclampsia and other pregnancy complications].
    Vucić N; Frleta M; Petrović D; Ostojić V
    Acta Med Croatica; 2009 Oct; 63(4):297-305. PubMed ID: 20034330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does low-molecular-weight heparin improve live birth rates in pregnant women with thrombophilic disorders? A systematic review.
    Tan WK; Lim SK; Tan LK; Bauptista D
    Singapore Med J; 2012 Oct; 53(10):659-63. PubMed ID: 23112017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials.
    Rodger MA; Gris JC; de Vries JIP; Martinelli I; Rey É; Schleussner E; Middeldorp S; Kaaja R; Langlois NJ; Ramsay T; Mallick R; Bates SM; Abheiden CNH; Perna A; Petroff D; de Jong P; van Hoorn ME; Bezemer PD; Mayhew AD;
    Lancet; 2016 Nov; 388(10060):2629-2641. PubMed ID: 27720497
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.